In addition, we performed an exploratory study to elucidate EZH2 protein expression in MTC tissue, as well as the expression of several other immunohistochemical markers with potential diagnostic or therapeutic value (prostate-specific membrane antigen [PSMA] and programmed death-ligand 1 [PD-L1]). Here, EZH2 is linked to medullary thyroid gland carcinoma.